Display Settings:

Format

Send to:

Choose Destination
    J Antimicrob Chemother. 2011 Mar;66(3):608-10. Epub 2011 Jan 7.

    Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures.

    Source

    Department of Pharmacy, Faculty of Health Sciences, University of Tromsø, 9037 Tromsø, Norway. paal.johnsen@uit.no

    Abstract

    OBJECTIVES:

    To estimate the relative fitness differences between glycopeptide-resistant Enterococcus faecium (GREF) and glycopeptide-susceptible E. faecium (GSEF) from yearly surveillance data on the occurrence of GREF in Danish poultry farm environments.

    METHODS:

    A population genetic model was adapted to retrospectively estimate the biological fitness cost of acquired resistance. Maximization of a likelihood function was used to predict the longitudinal persistence of acquired resistance.

    RESULTS:

    Our analysis suggests strong selection against GREF following the 1995 ban on the glycopeptide growth promoter avoparcin. However, parameterizing the model with two selection coefficients suggesting a reduced negative effect of the acquired resistance on bacterial fitness over time significantly improved the fit of the model. Our analyses suggest that the acquired glycopeptide resistance will persist for >25 years.

    CONCLUSIONS:

    Acquired resistance determinants in commensal E. faecium populations in Danish farm environments are likely to persist for decades, even in the absence of glycopeptide use.

    PMID:
    21217128
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3037156
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk